Wednesday, July 8, 2026

pharma · Colonic disease

Norgine

Norgine clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Amsterdam, NL HQ
1906 Founded
1,160 Employees
TGA registrant Type
Company details
Status
Public
HQ
Amsterdam, NL
Founded
1906
Employees
1,160
Programs
1
Drugs
3
Patents
0
Intelligence · Clinical Programs

Norgine projects

1 ClinicalTrials.gov programs sponsored by Norgine.

Norgine has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. NER1006-01/2025

    Norgine Pty.

    Colonic disease

    phase 3 small molecule active

    1 trial

Frequently asked questions

How many clinical projects does Norgine have?

1 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.